154 related articles for article (PubMed ID: 17875234)
1. Prothrombotic coagulation abnormalities in patients with paraprotein-producing B-cell disorders.
Auwerda JJ; Sonneveld P; de Maat MP; Leebeek FW
Clin Lymphoma Myeloma; 2007 Jul; 7(7):462-6. PubMed ID: 17875234
[TBL] [Abstract][Full Text] [Related]
2. Preferential expression of human lambda-light-chain variable-region subgroups in multiple myeloma, AL amyloidosis, and Waldenström's macroglobulinemia.
Ozaki S; Abe M; Wolfenbarger D; Weiss DT; Solomon A
Clin Immunol Immunopathol; 1994 May; 71(2):183-9. PubMed ID: 8181187
[TBL] [Abstract][Full Text] [Related]
3. Paraproteins: a regional South Australian experience.
Roberts-Thomson PJ; Nikoloutsopoulos T; Smith AJ
Asian Pac J Allergy Immunol; 2002 Sep; 20(3):187-95. PubMed ID: 12587843
[TBL] [Abstract][Full Text] [Related]
4. CD4⁺ T cells in chronic autoantigenic stimulation in MGUS, multiple myeloma and Waldenström's macroglobulinemia.
Neumann F; Pfreundschuh M; Preuss KD; Schormann C; Zwick C; Murawski N; Kubuschok B
Int J Cancer; 2015 Sep; 137(5):1076-84. PubMed ID: 25677163
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Cesana C; Klersy C; Barbarano L; Nosari AM; Crugnola M; Pungolino E; Gargantini L; Granata S; Valentini M; Morra E
J Clin Oncol; 2002 Mar; 20(6):1625-34. PubMed ID: 11896113
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of protein-phosphatase 2A causing hyperphosphorylation of autoantigenic paraprotein targets in MGUS/MM is due to an exchange of its regulatory subunits.
Preuss KD; Fadle N; Regitz E; Held G; Pfreundschuh M
Int J Cancer; 2014 Nov; 135(9):2046-53. PubMed ID: 24676687
[TBL] [Abstract][Full Text] [Related]
7. Primary systemic amyloidosis: a rare complication of immunoglobulin M monoclonal gammopathies and Waldenström's macroglobulinemia.
Gertz MA; Kyle RA; Noel P
J Clin Oncol; 1993 May; 11(5):914-20. PubMed ID: 8487054
[TBL] [Abstract][Full Text] [Related]
8. Macroglobulinemia-myeloma double gammopathy. A study of four cases and a review of the literature.
Pruzanski W; Underdown B; Silver EH; Katz A
Am J Med; 1974 Aug; 57(2):259-66. PubMed ID: 4211040
[No Abstract] [Full Text] [Related]
9. Hemostatic abnormalities in multiple myeloma and related disorders.
Glaspy JA
Hematol Oncol Clin North Am; 1992 Dec; 6(6):1301-14. PubMed ID: 1452513
[TBL] [Abstract][Full Text] [Related]
10. Ocular manifestations of multiple myeloma, Waldenström's macroglobulinemia and benign monoclonal gammopathy.
Orellana J; Friedman AH
Surv Ophthalmol; 1981; 26(3):157-69. PubMed ID: 6801795
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal gammopathy of undetermined significance.
Kyle RA
Blood Rev; 1994 Sep; 8(3):135-41. PubMed ID: 7819815
[TBL] [Abstract][Full Text] [Related]
12. [Monoclonal gammopathies of undetermined significance].
Hofmann V
Schweiz Med Wochenschr; 1982 Nov; 112(48):1718-23. PubMed ID: 6817412
[TBL] [Abstract][Full Text] [Related]
13. Prothrombotic coagulation abnormalities in patients with newly diagnosed multiple myeloma.
Auwerda JJ; Sonneveld P; de Maat MP; Leebeek FW
Haematologica; 2007 Feb; 92(2):279-80. PubMed ID: 17296591
[TBL] [Abstract][Full Text] [Related]
14. Extremely high levels of von Willebrand factor antigen and of procoagulant factor VIII found in multiple myeloma patients are associated with activity status but not with thalidomide treatment.
Minnema MC; Fijnheer R; De Groot PG; Lokhorst HM
J Thromb Haemost; 2003 Mar; 1(3):445-9. PubMed ID: 12871448
[TBL] [Abstract][Full Text] [Related]
15. A Rare Case of Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma with Light Chain Discrepancy between B Lymphocyte Population and Serum Paraprotein.
Kim HJ; Hur M; Kim H; Moon HW; Yun YM; Kim SY; Lee MH
Ann Clin Lab Sci; 2015; 45(5):593-7. PubMed ID: 26586715
[TBL] [Abstract][Full Text] [Related]
16. Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study.
Kristinsson SY; Pfeiffer RM; Björkholm M; Goldin LR; Schulman S; Blimark C; Mellqvist UH; Wahlin A; Turesson I; Landgren O
Blood; 2010 Jun; 115(24):4991-8. PubMed ID: 20299513
[TBL] [Abstract][Full Text] [Related]
17. Deposits of paraprotein in small vessels as a cause of skin ulcers in Waldenström's macroglobulinemia.
Wagner DR; Eckert F; Gresser U; Landthaler M; Middeke M; Zöllner N
Clin Investig; 1993 Dec; 72(1):46-9. PubMed ID: 8136617
[TBL] [Abstract][Full Text] [Related]
18. Abnormalities in lymphocyte profile and specificity repertoire of patients with Waldenstrom's macroglobulinemia, multiple myeloma, and IgM monoclonal gammopathy of undetermined significance.
Pilarski LM; Andrews EJ; Serra HM; Ledbetter JA; Ruether BA; Mant MJ
Am J Hematol; 1989 Feb; 30(2):53-60. PubMed ID: 2536515
[TBL] [Abstract][Full Text] [Related]
19. [B lymphoproliferative syndrome with characteristics common to chronic lymphatic leukemia, Waldenström disease and plasmacytic leukemia].
Tosato F; Fossaluzza V; Sala P; Tonutti E
Minerva Med; 1984 Nov; 75(44):2691-4. PubMed ID: 6440066
[TBL] [Abstract][Full Text] [Related]
20. Lupus anticoagulant and Waldenstrom's macroglobulinemia.
Maldonado N; González A; Asmar S; Robert F; Cruz Vidal M; Fraguada L
Bol Asoc Med P R; 1988 Nov; 80(11):408-12. PubMed ID: 3146257
[No Abstract] [Full Text] [Related]
[Next] [New Search]
